HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
HUTCHMED (China) Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$14.18+0.13 (+0.93%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 27.3
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4M
Shares held, 13F filers
Institutional holders
56
8 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HCM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Schroder Investment Management Group | 1,477,494 | – | $15.82M | – | 0.01% |
| Allianz Asset Management GmbH | 837,475 | – | $12.53M | – | 0.01% |
| State Street Corp | 313,611 | – | $3.37M | +8,782 | 0.00% |
| AIA Group Ltd | 291,229 | – | $3.13M | – | 0.04% |
| M&g PLC | 242,791 | – | $2.67M | −12,677 | 0.01% |
| Amundi | 204,385 | – | $2.20M | −27,861 | 0.00% |
| Jane Street Group, LLC | 194,472 | – | $2.09M | +117,958 | 0.00% |
| Renaissance Technologies LLC | 130,200 | – | $1.40M | −1,862 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 104,425 | – | $1.12M | −2,079 | 0.00% |
| XY Capital Ltd | 104,130 | – | $1.12M | +55,736 | 1.08% |
| Crossmark Global Holdings, Inc. | 84,915 | – | $913.69K | −48 | 0.01% |
| Acadian Asset Management LLC | 65,166 | – | $696 | +65,157 | 0.00% |
| Two Sigma Investments, LP | 63,248 | – | $680.55K | New | 0.00% |
| UBS Group AG | 44,183 | – | $475.41K | −575 | 0.00% |
| Vanguard Personalized Indexing Management, LLC | 42,599 | – | $458.37K | +22,174 | 0.00% |
| Dimensional Fund Advisors LP | 38,967 | – | $419.29K | −17,002 | 0.00% |
| Citadel Advisors LLC | 38,061 | – | $409.54K | +7,547 | 0.00% |
| Vident Advisory, LLC | 26,584 | – | $286.04K | +8,858 | 0.00% |
| Millennium Management LLC | 26,420 | – | $284.28K | −1,594 | 0.00% |
| StoneX Group Inc. | 18,262 | – | $213.56K | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 4M | 8 / 15 | 22 / 5 | 0M | 0M |
| Q1 2026 | 54 | 4M | 9 / 14 | 19 / 4 | 0M | 1M |
| Q4 2025 | 50 | 5M | 3 / 16 | 17 / 11 | 0M | 1M |
| Q3 2025 | 58 | 6M | 3 / 19 | 22 / 8 | 0M | 1M |
| Q2 2025 | 63 | 6M | 8 / 19 | 20 / 8 | 0M | 1M |
| Q1 2025 | 63 | 7M | 2 / 17 | 31 / 8 | 0M | 1M |
| Q4 2024 | 69 | 7M | 10 / 17 | 25 / 7 | 1M | 1M |
| Q3 2024 | 66 | 7M | 8 / 18 | 20 / 8 | 0M | 2M |
| Q2 2024 | 67 | 9M | 11 / 16 | 26 / 15 | 0M | 6M |
| Q1 2024 | 71 | 15M | 10 / 22 | 25 / 9 | 1M | 1M |
| Q4 2023 | 71 | 15M | 7 / 22 | 26 / 1 | 1M | 9M |
| Q3 2023 | 65 | 23M | 9 / 14 | 23 / 14 | 1M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of HCM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Steward Values Enhanced International Fund | 84,097 | – | $936.00K | 0.28% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 70,063 | – | $753.88K | 0.00% | Jun 30, 2026 |
| Tema Oncology ETF | 67,823 | – | $776.57K | 0.44% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 21,833 | – | $249.99K | 0.00% | May 31, 2026 |
| National Security Emerging Markets Index ETF | 7,512 | – | $86.01K | 0.21% | May 31, 2026 |
| Dimensional Emerging Markets Core Equity 2 ETF | 5,574 | – | $62.04K | 0.00% | Jul 31, 2026 |
| Dimensional World ex. U.S. Core Equity 2 ETF | 2,110 | – | $23.48K | 0.00% | Jul 31, 2026 |
| Emerging Markets Core Equity 2 Portfolio | 1,681 | – | $18.71K | 0.00% | Jul 31, 2026 |
| Dimensional Emerging Markets Sustainability Core 1 ETF | 1,312 | – | $14.60K | 0.00% | Jul 31, 2026 |
| Emerging Markets Sustainability Core 1 Portfolio | 1,241 | – | $13.81K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Chig Fung Cheng | Acting CEO and CFO, Director | 56,693 | May 21, 2026 |
| Wei-guo Su | CEO and CSO, Director | 3,563,905 | May 21, 2026 |
| Charles George Rupert Nixon | Group General Counsel | 41,763 | May 21, 2026 |
| Lorenso Chiu | Deputy Chief Financial Officer | 8,475 | May 21, 2026 |
| Renu Bhatia | Director | 16,000 | Mar 10, 2026 |
| Ling Yang | Director | – | Mar 10, 2026 |
| Tak Wai Wong | Director | – | Mar 10, 2026 |
| Daniel Shao Weng Tan | Director | – | Mar 10, 2026 |
| Dan Eldar | Director | 19,000 | Mar 10, 2026 |
| Chaohong Hu | Director | – | Mar 10, 2026 |
| Edith Shih | Director | 100,000 | Mar 10, 2026 |
| Tony Shu Kam Mok | – | 27,341 | May 13, 2026 |